IP Library › Granted Patent US 11,771,091
Granted Patent B2
US 11,771,091 · App. 16/729,240 · Granted Oct 3, 2023

Non-toxic plant agent compositions and methods and uses thereof

Inventors: Parker Dale (Newport Beach, CA); Parker David Dale (Newport Beach, CA)
Assignee: Neozyme International, Inc.
A01N63/30A01N63/20A01N63/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,771,091
App. No.
16/729,240
Granted
Oct 3, 2023
Kind
B2
Abstract

The present specification discloses plant agent compositions, articles of manufacture, containers or kits comprising such compositions, and methods and uses to control a causal agent of a plant disease or increasing plant growth and/or fruit production.

Claims (17)

1. A dry powdered composition comprising at most 20.0% by weight of a dried treated, fermented yeast supernatant including bio-nutrients, minerals and amino acids, and one or more nonionic biosurfactants, wherein the composition lacks active enzymes contributed by yeast during fermentation due to the treatment.

2. The dry powdered composition according to claim 1 , wherein the dried treated, fermented yeast supernatant is produced from a culture containing yeast belonging to the genus Brettanomyces, Candida, Cyberlindnera, Cystofilobasidium, Debaryomyces, Dekkera, Geotrichum, Issatchenkia, Kazachstania, Kloeckera, Kluyveromyces, Pichia, Rhodosporidium, Rhodotorula, Saccharomyces, Schizosaccharomyces, Thrichosporon, Torulaspora, Torulopsis, Yarrowia, Zygosaccharomyces , or Zygotorulaspora.

3. The dry powdered composition according to claim 1 , comprising at most 15% by weight of the dried treated, fermented yeast supernatant.

4. The dry powdered composition according to claim 3 , comprising at most 10% by weight of the dried treated, fermented yeast supernatant.

5. The dry powdered composition according to claim 1 , comprising about 5% to about 15% by weight of the dried treated, fermented yeast supernatant.

6. The dry powdered composition according to claim 5 , comprising about 5% to about 10% by weight of the dried treated, fermented yeast supernatant.

7. The dry powdered composition according to claim 1 , comprising at least 10.0% by weight of the one or more nonionic biosurfactants.

8. The dry powdered composition according to claim 1 , being non-toxic to humans, mammals, plants or the environment.

9. The dry powdered composition according to claim 1 , wherein the dry powdered composition does not contain any ionic surfactants.

10. The dry powdered composition according to claim 1 , further comprising an antimicrobial.

11. The dry powdered composition according to claim 1 comprising at least 10.0% by weight of the one or more nonionic biosurfactants, and wherein the dried treated, fermented yeast supernatant is produced from a culture containing yeast belonging to the genus Saccharomyces.

12. The dry powdered composition according to claim 11 , wherein the yeast is Saccharomyces cerevisiae.

13. The dry powdered composition according to claim 11 , comprising at most 15.0% by weight of a dried treated, fermented yeast supernatant.

14. The dry powdered composition according to claim 13 , comprising at most 10% by weight of the dried treated, fermented yeast supernatant.

15. The dry powdered composition according to claim 11 , comprising about 5% to about 15% by weight of the dried treated, fermented yeast supernatant.

16. The dry powdered composition according to claim 15 , comprising about 5% to about 10% by weight of the dried treated, fermented yeast supernatant.

17. The dry powdered composition according to claim 11 , being non-toxic to humans, mammals, plants or the environment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2020
From: DALE, PARKER; DALE, PARKER DAVID
To: NEOZYME INTERNATIONAL, INC.
Reel/Frame 051834/0240 →
Continuity (5)
Continuation 15243961 · Aug 22, 2016
Continuation In Part 14404917
Provisional Application 62208662 · Aug 22, 2015
Provisional Application 61689077 · May 29, 2012
Related Publication 20200138037A1 · May 7, 2020